Standardized SEC financial data for EASTGATE BIOTECH CORP — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001099574 · Investors, NEC.
Ratios for fiscal year 2015, standardized from SEC filings.
| USD | FY2016 |
|---|---|
| R&D expense | $502K |
| SG&A expense | $1.8M |
| Operating income | -$2.6M |
| Interest expense | $160K |
| Pretax income | -$3.0M |
| Net income | -$3.0M |
Standardized from EASTGATE BIOTECH CORP's SEC filings — per-share figures split-adjusted. Full history via the API.
| USD | FY2016 |
|---|---|
| Cash & equivalents | $0 |
| Total assets | $0 |
| Total current liabilities | $4.6M |
| Long-term debt | $40K |
| Total debt | $40K |
| Total liabilities | $4.6M |
| Retained earnings | -$14.6M |
| Total equity | -$4.6M |
| USD | FY2016 |
|---|---|
| Operating cash flow | -$389K |
| Financing cash flow | $322K |
| Dividends paid | $0 |
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001099574/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001099574/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"